Literature DB >> 15777771

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects.

Brian A Hoshaw1, Jessica E Malberg, Irwin Lucki.   

Abstract

Drug development research has identified neurotrophic factors as a downstream target of chronic antidepressant treatments. In order to study their antidepressant-like effects, two neurotrophic factors, brain-derived neurotrophic factor and insulin-like growth factor I, were examined in the rat modified forced swimming test after a single icv administration. Both neurotrophins produced antidepressant-like behavioral effects in the modified rat forced swimming test, reducing immobility and increasing swimming. In contrast to currently used antidepressants, which produce acute effects in the forced swimming test, the effects of the neurotrophins were unusually long lasting and persisted at least 6 days after the treatment. Neither neurotrophic factor had an effect on locomotor activity. The results support a role for neurotrophic factors mediating the behavioral effects of antidepressant drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15777771     DOI: 10.1016/j.brainres.2005.01.007

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  117 in total

Review 1.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

Review 2.  Linking molecules to mood: new insight into the biology of depression.

Authors:  Vaishnav Krishnan; Eric J Nestler
Journal:  Am J Psychiatry       Date:  2010-09-15       Impact factor: 18.112

3.  Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.

Authors:  Heath D Schmidt; Ronald S Duman
Journal:  Neuropsychopharmacology       Date:  2010-08-04       Impact factor: 7.853

4.  The GABAergic deficit hypothesis of major depressive disorder.

Authors:  B Luscher; Q Shen; N Sahir
Journal:  Mol Psychiatry       Date:  2010-11-16       Impact factor: 15.992

5.  Peripheral insulin-like growth factor-I produces antidepressant-like behavior and contributes to the effect of exercise.

Authors:  Catharine H Duman; Lee Schlesinger; Rosemarie Terwilliger; David S Russell; Samuel S Newton; Ronald S Duman
Journal:  Behav Brain Res       Date:  2008-11-14       Impact factor: 3.332

6.  Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission.

Authors:  Brian A Hoshaw; Tiffany I Hill; James J Crowley; Jessica E Malberg; Xavier Khawaja; Sharon Rosenzweig-Lipson; Lee E Schechter; Irwin Lucki
Journal:  Eur J Pharmacol       Date:  2008-07-17       Impact factor: 4.432

7.  Novel antidepressant effects of Paeonol alleviate neuronal injury with concomitant alterations in BDNF, Rac1 and RhoA levels in chronic unpredictable mild stress rats.

Authors:  Xiu-Ling Zhu; Jing-Jing Chen; Fei Han; Chuan Pan; Ting-Ting Zhuang; Ya-Fei Cai; Ya-Ping Lu
Journal:  Psychopharmacology (Berl)       Date:  2018-05-12       Impact factor: 4.530

8.  A novel 5HT3 receptor-IGF1 mechanism distinct from SSRI-induced antidepressant effects.

Authors:  M Kondo; Y Koyama; Y Nakamura; S Shimada
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992

9.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 10.  Exercise and brain health--implications for multiple sclerosis: Part 1--neuronal growth factors.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.